Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib.
J Invest Dermatol
; 134(4): 992-1000, 2014 Apr.
Article
in En
| MEDLINE
| ID: mdl-24213371
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperidines
/
Pyrimidines
/
Pyrroles
/
CD8-Positive T-Lymphocytes
/
Protein Kinase Inhibitors
/
Dermatitis
/
Graft vs Host Disease
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Invest Dermatol
Year:
2014
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos